Erik Frostberg

Dr. Erik Frostberg

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

26 April 2020 in Acta Radiologica
Verified
Journal Article
Closed access
PDF file
EFErik Frostberg
Erik Frostberg
Malene Roland Vils PedersenMalene Roland Vils Pedersen
Malene Roland Vils Pedersen
YMYavar Manhoobi
Yavar Manhoobi
HRHans B Rahr
Hans B Rahr
Søren Rafael RafaelsenSøren Rafael Rafaelsen
Søren Rafael Rafaelsen
Background: Obesity can be measured by different indices, either as body mass index (BMI) or by more intuitive radiological measurements, and obesity has been shown to have an impact on outcome after colorectal cancer (CRC) surgery. Purpose: To investigate whether the thickness of the subcutaneous adipose tissue (SAT) in the abdominal wall can be used as a surrogate for the visceral fat area (VFA)—both measured on computed tomography (CT)—in prediction of short- and long-term outcomes after elective CRC surgery. Material and Methods: Preoperative CT scans of all patients having elective CRC surgery (stages I–III), in two consecutive years at a single-center institution, were used to measure the SAT (mm) and VFA (cm2). BMI was calculated for each patient. The three different obesity indices were used in different analyses in order to predict postoperative complications and overall survival. Results: A BMI >30 kg/m2 was an independent prognostic factor in postoperative complications (odds ratio 3.2, 95% confidence interval [CI] 1.43–7.03). SAT and VFA were not able to predict complications. Patients considered visceral obese according to a high VFA (>130 cm2) had poorer survival (hazard ratio 1.53, 95% CI 1.00–2.36) compared to non-obese patients, but in the adjusted model, VFA lost its predictive power. BMI and SAT were not able to predict mortality. Conclusion: The novel measurement of the thickness of SAT in a preoperative setting before elective CRC surgery cannot predict either postoperative complications or overall survival; the other obesity indices had better predictive features.

24 April 2014 in BMC Surgery
Verified
Journal Article
Open access
PDF file
EFErik Frostberg
Erik Frostberg
PSPetter Ström
Petter Ström
Oke GerkeOke Gerke
Oke Gerke
NQNiels Qvist
Niels Qvist
Infliximab, a TNF-α inhibitor, is a potent anti-inflammatory drug in the treatment of inflammatory bowel diseases. Recent studies have investigated the effect of infliximab treatment on postoperative complications such as anastomotic leakage, however, with conflicting results and conclusions. The purpose of this study was to investigate whether a single dose infliximab has an adverse effect on the anastomotic healing process, observed as reduced anastomotic breaking strength and histopathologically verified lower grade of inflammatory response, in the small intestine of a rabbit.

20 December 2024 in Cancer Epidemiology
Verified
Journal Article
Open access
AHAnne Sofie Krogh Holdam
Anne Sofie Krogh Holdam
VKVibeke Koudahl
Vibeke Koudahl
EFErik Frostberg
Erik Frostberg
KRKarina Rønlund
Karina Rønlund
HRHans Bjarke Rahr
Hans Bjarke Rahr
The incidence of keratinocyte carcinoma (KC), i.e., basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is increasing worldwide, placing a significant burden on healthcare resources. This is especially the case for tumors requiring surgical intervention. It remains unclear whether this increase is a result of the population aging or a genuine increase in risk of skin cancer. Understanding age-adjusted incidence trends of KC is crucial for improving future management of the disease. We studied these trends in a large nationwide cohort, focusing on large, invasive, and surgically challenging tumors. Information on all incident cases of BCC and SCC in Denmark was extracted from population-based databases in the calendar years 2007-2021. Age-adjusted incidence rates were calculated, standardized to the 2013 European Standard Population. Average annual percentage changes were estimated using Joinpoint regression models. Incidence trends for larger, more invasive tumors (tumor (T) category of ≥T2), and of those in the head and neck area, were elucidated with descriptive statistics. We found 183,338 patients with a first-time incidence of BCC and 42,233 patients with a first-time incidence of SCC in the period 2007-2021. The incidence rate, adjusted for age, increased from 252 to 338 per 100,000 for BCC and from 49 to 104 per 100,000 for SCC. For SCC, the increase was particularly pronounced in the last two years of the study period. Tumors ≥T2, and those in the head and neck area, increased markedly. KC is the most common type of cancer worldwide, and the age-adjusted incidence rates of BCC and SCC increased significantly from 2007 to 2021, as did tumors with a higher T category and those located in anatomically sensitive areas. Since the primary treatment for many of these tumors is surgical, this raises concern about the strain on future healthcare resources.

12 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
EFErik Frostberg
Erik Frostberg
APAnnabeth Høgh Petersen
Annabeth Høgh Petersen
ABAnders Bojesen
Anders Bojesen
HRHans Bjarke Rahr
Hans Bjarke Rahr
JLJan Lindebjerg
Jan Lindebjerg
KRKarina Rønlund
Karina Rønlund
Introduction: The prevalence of pathogenic or likely pathogenic germline variants (PGV) in colorectal cancer (CRC) in young patients is seen in approximately one in five patients, with the majority of cases having gene variants associated with Lynch syndrome (LS). The primary aim was to describe the prevalence of 18 genes, all associated with hereditary polyposis and CRC, in a nationwide population of young CRC (yCRC) patients, and outline disease characteristics in patients with or without germline variants. Methods: We screened 98 patients aged 18–40 with CRC diagnosed in 2010–2013 for variants in MSH2, MSH6, MLH1, PMS2, EPCAM, APC, MUTYH, SMAD4, BMPR1A, STK11, PTEN, POLE, POLD1, NTHL1, AXIN2, MSH3, GREM1 and RNF43 using Next Generation Sequencing. Comparisons between patients’ characteristics in patients with PGV, and patients without germline variants (NPGV) were analyzed. Results: PGV were detected in twenty-four patients (24.5%), and twenty-one patients (21.1%) had variants in the mismatch repair (MMR) genes associated with LS. Variants in the APC and MUTYH genes were detected in 1% and 4%, respectively. Patients with NPGV had more advanced disease with adverse histopathological features. Conclusion: PGV was detected in one in four yCRC patients, and one in five yCRC patients had disease causing variants in the mismatch repair genes associated with LS.

12 February 2022 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
HWHelene Juul Wurtz
Helene Juul Wurtz
LBLars Bundgaard
Lars Bundgaard
HRHans Bjarke Rahr
Hans Bjarke Rahr
EFErik Frostberg
Erik Frostberg